{"disease":{"id":"thrombotic-thrombocytopenic-purpura-ttp","name":"thrombotic thrombocytopenic purpura ttp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07429942","title":"A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":94,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04683003","title":"A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":77,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03393975","title":"A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT07353099","title":"A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06945861","title":"Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)","phase":"","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT06441578","title":"A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05714969","title":"A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03922308","title":"Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02216084","title":"Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT05393999","title":"SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":false},{"nct_id":"NCT05770219","title":"Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Takeda","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}